MIDDLEKAUFF W BRADFORD 4
4 · Edge Therapeutics, Inc. · Filed Mar 18, 2019
Insider Transaction Report
Form 4
MIDDLEKAUFF W BRADFORD
Senior VP, GC and Secretary
Transactions
- Exercise/Conversion
Restricted Stock Units
2019-03-15−49,766→ 0 total→ Common Stock (49,766 underlying) - Exercise/Conversion
Common Stock
2019-03-15+49,766→ 59,766 total
Holdings
- 14,004.09(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]Vesting of RSUs granted to the Reporting Person on August 14, 2018.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit.
- [F3]These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria.
- [F4]Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest.